Search filters

List of works by Nobuharu Tamaki

Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma

scientific article published on 27 August 2019

Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic Hepatitis C

scientific article published on 05 September 2020

Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases

scientific article published on 01 January 2021

Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B

scientific article published on 29 January 2020

Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib

scientific article published on 16 October 2020

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

scientific article published on August 1, 2010

Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma

scientific article

Expression of Keratin 19 Is Related to High Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation

scientific article published on July 7, 2011

Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy

scientific article published on September 1, 2010

Hepatitis B surface antigen reduction as a result of switching from long-term entecavir administration to tenofovir

scientific article published on 24 October 2019

Hepatitis B surface antigen reduction by switching from long-term nucleoside/nucleotide analogue administration to pegylated interferon.

scientific article published on 15 February 2017

Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus

scientific article published in 2021

Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatoce

scientific article published on 17 October 2016

L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis

scientific article published on 9 December 2014

Living in the non‐alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives

scientific article published on 06 July 2022

New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode

scientific article published on 27 August 2019

Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications

scientific article published on 15 October 2014

Non-invasive liver fibrosis assessment correlates with collagen and elastic fiber quantity in patients with hepatitis C virus infection

scientific article published on 26 December 2018

Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients

scientific article published on 15 December 2013

Noninvasive estimation of fibrosis progression overtime using the FIB‐4 index in chronic hepatitis C

scientific article published on July 4, 2012

Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures

scientific article published on 15 February 2019

Relationship between Polymorphisms of the Inosine Triphosphatase Gene and Anaemia or Outcome after Treatment with Pegylated Interferon and Ribavirin

scientific article published on January 1, 2011

Reply

scientific article published on 30 January 2019

Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy

scientific article published on 14 September 2015

Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals

scientific article published on 03 May 2019

Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma

scientific article

Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice

scientific article published on 09 October 2019

Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis

scientific article published on 13 September 2020

Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate

scientific article published on 21 May 2019

Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib

scientific article published on 06 September 2019

Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization

scientific article published on 26 December 2017

Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites

scientific article published on 26 November 2015

Use of the Serum Wisteria floribunda Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C Patients

scientific article published on 22 March 2020

Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma

scientific article published in 2022

Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis

scientific article published on 09 June 2020

Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog

scientific article published on 23 January 2020

Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup

scientific article published on 22 December 2020

Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients

scientific article

Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virus

scientific article published on 23 August 2018

Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease

scientific article published on 12 July 2019